218 related articles for article (PubMed ID: 23549034)
1. [Application for academic multicenter studies at German ethical review boards].
Gökbuget N; Naumann R;
Onkologie; 2013; 36 Suppl 2():29-35. PubMed ID: 23549034
[TBL] [Abstract][Full Text] [Related]
2. Ontario Cancer Research Ethics Board: lessons learned from developing a multicenter regional institutional review board.
Saginur R; Dent SF; Schwartz L; Heslegrave R; Stacey S; Manzo J
J Clin Oncol; 2008 Mar; 26(9):1479-82. PubMed ID: 18349399
[TBL] [Abstract][Full Text] [Related]
3. The paradoxical problem with multiple-IRB review.
Menikoff J
N Engl J Med; 2010 Oct; 363(17):1591-3. PubMed ID: 20942660
[No Abstract] [Full Text] [Related]
4. Transitioning to the National Institutes of Health single institutional review board model: Piloting the use of the Streamlined, Multi-site, Accelerated Resources for Trials IRB Reliance.
Vardeny O; Hernandez AF; Cohen LW; Franklin A; Baqai M; Palmer S; Bierer BE; Cobb N
Clin Trials; 2019 Jun; 16(3):290-296. PubMed ID: 30866676
[TBL] [Abstract][Full Text] [Related]
5. [Duration and variation of the ethics approval process in Germany - an example from a non-interventional study with 44 participating centers].
Eichler M; Schmitt J; Schuler MK
Z Evid Fortbild Qual Gesundhwes; 2019 Oct; 146():15-20. PubMed ID: 31473073
[TBL] [Abstract][Full Text] [Related]
6. Review of multicenter studies by multiple institutional review boards: characteristics and outcomes for perinatal studies implemented by a multicenter network.
Abramovici A; Salazar A; Edvalson T; Gallagher N; Dorman K; Tita A;
Am J Obstet Gynecol; 2015 Jan; 212(1):110.e1-6. PubMed ID: 25088862
[TBL] [Abstract][Full Text] [Related]
7. Should society allow research ethics boards to be run as for-profit enterprises?
Emanuel EJ; Lemmens T; Elliot C
PLoS Med; 2006 Jul; 3(7):e309. PubMed ID: 16848618
[TBL] [Abstract][Full Text] [Related]
8. Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literature.
Check DK; Weinfurt KP; Dombeck CB; Kramer JM; Flynn KE
Clin Trials; 2013 Aug; 10(4):560-7. PubMed ID: 23666951
[TBL] [Abstract][Full Text] [Related]
9. A review finds that multicenter studies face substantial challenges but strategies exist to achieve Institutional Review Board approval.
Greene SM; Geiger AM
J Clin Epidemiol; 2006 Aug; 59(8):784-90. PubMed ID: 16828670
[TBL] [Abstract][Full Text] [Related]
10. Approaches to facilitate institutional review board approval of multicenter research studies.
Marsolo K
Med Care; 2012 Jul; 50 Suppl():S77-81. PubMed ID: 22692264
[TBL] [Abstract][Full Text] [Related]
11. An Institutional Review Board dilemma: responsible for safety monitoring but not in control.
DeMets DL; Fost N; Powers M
Clin Trials; 2006; 3(2):142-8. PubMed ID: 16773956
[TBL] [Abstract][Full Text] [Related]
12. Reducing the burden on many institutional review boards.
Maloney DM
Hum Res Rep; 2003 Jun; 18(6):1-2. PubMed ID: 15119341
[No Abstract] [Full Text] [Related]
13. [Ethics of observational studies: are specific rules useful?].
Rosmini F
Epidemiol Prev; 2006; 30(4-5):295-7. PubMed ID: 17176945
[No Abstract] [Full Text] [Related]
14. Variation in standards of research compensation and child assent practices: a comparison of 69 institutional review board-approved informed permission and assent forms for 3 multicenter pediatric clinical trials.
Kimberly MB; Hoehn KS; Feudtner C; Nelson RM; Schreiner M
Pediatrics; 2006 May; 117(5):1706-11. PubMed ID: 16651328
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the ethical review process for non-pharmacological multicentre studies in Germany on the basis of a randomised surgical trial.
Seiler CM; Kellmeyer P; Kienle P; Büchler MW; Knaebel HP;
J Med Ethics; 2007 Feb; 33(2):113-8. PubMed ID: 17264200
[TBL] [Abstract][Full Text] [Related]
16. Views of the process and content of ethical reviews of HIV vaccine trials among members of US institutional review boards and South African research ethics committees.
Klitzman R
Dev World Bioeth; 2008 Dec; 8(3):207-18. PubMed ID: 19046258
[TBL] [Abstract][Full Text] [Related]
17. Variation in institutional review board responses to a standard, observational, pediatric research protocol.
Mansbach J; Acholonu U; Clark S; Camargo CA
Acad Emerg Med; 2007 Apr; 14(4):377-80. PubMed ID: 17312334
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for promoting international multi-site clinical trials-from a viewpoint of ethics review.
Nakada H; Hasthorpe S; IJsselmuiden C; Kombe F; Ba M; Matei M; Nakamura K; Ushirozawa N; Fujiwara Y; Tashiro S
Dev World Bioeth; 2019 Dec; 19(4):192-195. PubMed ID: 31513337
[No Abstract] [Full Text] [Related]
19. Ethics committee reviews and mutual acceptance: a pilot study.
Rosenthal MA; Sarson-Lawrence M; Alt C; Arkell K; Dodds M;
Intern Med J; 2005 Nov; 35(11):650-4. PubMed ID: 16248858
[TBL] [Abstract][Full Text] [Related]
20. Using central IRBs for multicenter clinical trials in the United States.
Flynn KE; Hahn CL; Kramer JM; Check DK; Dombeck CB; Bang S; Perlmutter J; Khin-Maung-Gyi FA; Weinfurt KP
PLoS One; 2013; 8(1):e54999. PubMed ID: 23383026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
